Solvonis Therapeutics【SVNS】銘柄情報

Solvonis Therapeutics Plc (SVNS) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.165

( - )

買値

0.16

売値

0.17

出来高

96,872

平均取引量 (3 か月)

30,814,659p

財務取引量

0.16 日の範囲 0.165

0.16 52 週間の範囲 0.395

時価総額

11.231M

企業価値

9.586M

前日終値

0.165

始値

0.165

時刻

55000

0.164

(O)

最終取引時間

18:41:51

VWAP

歳入

純利益

-5.74M

発行済株式数

6,806,403,493

浮動株比率 (%)

67.26%

機関投資家保有比率 (%)

49.79%

配当利回り

PER

-1.4

株価売上高倍率 (PSR)

1 株当たり利益 (EPS)

-0

ベータ

1.21

Solvonis Therapeutics plc, a clinical-stage biopharmaceutical company, develops medicines for addiction, psychiatry, and neurology disorders. The company develops SVN-001, an NMDA receptor antagonist that is in Phase III clinical trial for the treatment of severe alcohol use disorder; and SVN-002, w... Solvonis Therapeutics plc, a clinical-stage biopharmaceutical company, develops medicines for addiction, psychiatry, and neurology disorders. The company develops SVN-001, an NMDA receptor antagonist that is in Phase III clinical trial for the treatment of severe alcohol use disorder; and SVN-002, which has completed Phase I clinical trial to treat moderate to severe alcohol use disorder. Its pre-clinical stage product consists of SVN-114 for the treatment of post-traumatic stress disorder; and SVN-015 for the treatment of stimulant use disorder. The company was formerly known as Graft Polymer (UK) Plc and changed its name to Solvonis Therapeutics plc in January 2025. Solvonis Therapeutics plc was incorporated in 2017 and is headquartered in London, the United Kingdom. 詳細を表示

セクター

Industrials

業界

Industrial Goods

ウェブサイト

solvonis.com

本社

London, United Kingdom

設立

2026

Solvonis Therapeutics Plc is listed in the Industrials sector of the ロンドン証券取引所 with ticker SVNS. The last closing price for Solvonis Therapeutics was 0.17p. Over the last year, Solvonis Therapeutics shares have traded in a share price range of 0.16p to 0.395p.

Solvonis Therapeutics currently has 6,806,403,493 shares in issue. The market capitalisation of Solvonis Therapeutics is £11.23 million. Solvonis Therapeutics has a price to earnings ratio (PE ratio) of -1.40.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.015	-8.33333333333	0.18	0.18	0.16	10021173	0.16667087	DE
4	-0.025	-13.1578947368	0.19	0.22	0.16	21033007	0.1957626	DE
12	-0.095	-36.5384615385	0.26	0.33	0.16	30346122	0.2382981	DE
26	-0.135	-45	0.3	0.33	0.16	32338248	0.24643496	DE
52	-0.105	-38.8888888889	0.27	0.395	0.16	45830398	0.29013384	DE
156	0	0	0.165	0.395	0.12	44807135	0.26192335	DE
260	0	0	0.165	0.395	0.12	44807135	0.26192335	DE